NCAM1 and lung cancer: Some of the selected antigens are used as diagnostic markers in lung cancer subtypes (TTF-1, MUC-1, HER, cytokeratin, and CD56), others as prognostic, proliferative, or immunosuppressive targets [16,17,18].